- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04571307
Cryotherapy in Breast B3 Lesions
August 31, 2021 updated by: KK Women's and Children's Hospital
Pilot Study on the Feasibility of Cryotherapy as an Alternative Treatment for Phyllodes Tumors/Breast Fibroepithelial Lesions (FELs) Needing Surgery
To determine the feasibility of cryotherapy for B3 fibroepithelial lesions
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Geok hoon Lim
- Phone Number: 96392353
- Email: lim.gh@singhealth.com.sg
Study Locations
-
-
-
Singapore, Singapore
- Recruiting
- KK Women's and Children's Hospital
-
Contact:
- Geok H Lim
- Phone Number: +6596392353 +6596392353
- Email: lim.gh@singhealth.com.sg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years to 71 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- lesion seen on ultrasound
- core biopsy revealed FEL of B3
- lesion </+3.5cm
- keen for cryotherapy instead of surgery
- has other breast lesions for followup
Exclusion Criteria:
- cancer patients
- patients with bleeding diathesis
- lesions causing visible breast deformity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
recurrence of the lesion
Time Frame: 2 years from procedure
|
assessed on ultrasound
|
2 years from procedure
|
|
breast cosmetic outcome
Time Frame: at 1 year post procedure
|
patient self assessment of excellent (1), good (2), fair (3) poor (4).
score of 1-4,1 being the best score
|
at 1 year post procedure
|
|
pain score
Time Frame: immediate post procedure
|
using pain score scale of 0-10, a higher score indicates a worse outcome
|
immediate post procedure
|
|
pain score
Time Frame: at 2 weeks post procedure
|
using pain score scale of 0-10, a higher score indicates a worse outcome
|
at 2 weeks post procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Geok hoon lim, KK Women's and Children's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 15, 2021
Primary Completion (Anticipated)
October 15, 2022
Study Completion (Anticipated)
October 15, 2022
Study Registration Dates
First Submitted
August 31, 2020
First Submitted That Met QC Criteria
September 25, 2020
First Posted (Actual)
October 1, 2020
Study Record Updates
Last Update Posted (Actual)
September 5, 2021
Last Update Submitted That Met QC Criteria
August 31, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019/2944
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Disease
-
Jose Ignacio SánchezWelwaze Medical Inc.Enrolling by invitationBreast Cancer | Benign Breast Disease | Breast DiseaseSpain
-
Zedsen LimitedImperial College Healthcare NHS TrustRecruitingBreast Cancer | Benign Breast DiseaseUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisInstitut PasteurCompleted
-
Brigham and Women's HospitalBreast Cancer Research Foundation; Partners in Health; Rwanda Biomedical CentreCompletedBreast Cancer | Benign Breast DiseaseRwanda
-
Tensive SRLCompleted
-
Brigham and Women's HospitalNational Cancer Institute (NCI)Active, not recruitingBenign Breast DiseaseUnited States
-
University of MichiganWayne State UniversityCompleted
-
National Cancer Institute (NCI)CompletedBenign Breast DiseaseUnited States
-
Seoul National University HospitalActive, not recruitingBreast Cancer | Breast Neoplasm | Ultrasonography | Artificial Intelligence | Benign Breast DiseaseKorea, Republic of
-
Alexandria UniversityCompletedBenign Breast Disease | Duct Ectasia BreastEgypt
Clinical Trials on cryotherapy
-
University Hospital, LilleAlmirall, SASNot yet recruiting
-
Weill Medical College of Cornell UniversityProstate Cancer FoundationRecruiting
-
Cairo UniversityNot yet recruiting
-
Creighton UniversityCompleted
-
Azienda Ospedaliera San Camillo ForlaniniCompleted
-
Hanyang University Seoul HospitalCompletedCryotherapy EffectKorea, Republic of
-
Chung Shan Medical UniversityCompleted
-
Ondokuz Mayıs UniversityCompletedPain, Postoperative | Pulpitis | Caries; DentinTurkey (Türkiye)
-
Jonsson Comprehensive Cancer CenterCompletedProstate Cancer | Prostate Adenocarcinoma | Prostate DiseaseUnited States
-
Stryker InstrumentsNorth American Science Associates Inc.Completed